Danaher beats Q2 profit estimates on strength in medical testing business

Go back to Danaher beats Q2 profit estimates on strength in medical testing business
Danaher Corp. (NYSE: DHR) Delayed: 204.85 -0.38 (0.19%)
Previous Close $205.23    52 Week High $102.79 
Open $206.00    52 Week Low $75.71 
Day High $206.05    P/E 53.91 
Day Low $201.95    EPS $3.80 
Volume 2,768,866